Results 271 to 280 of about 948,853 (295)

The adenosine pathway in immuno-oncology

Nature Reviews Clinical Oncology, 2020
Bertrand Allard, Laurence Buisseret, John Stagg   +2 more
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Fadlo R Khuri
exaly  

Lineage plasticity in cancer: a shared pathway of therapeutic resistance

Nature Reviews Clinical Oncology, 2020
Helena A Yu, Dana Pe'er, Charles L Sawyers   +2 more
exaly  

Poly(ADP-Ribose) polymerase (PARP) inhibitors: Exploiting a synthetic lethal strategy in the clinic

Ca-A Cancer Journal for Clinicians, 2011
Timothy A Yap, Johann Sebastian de Bono
exaly  

Materials design for bone-tissue engineering

Nature Reviews Materials, 2020
Mani Diba, Antonios G Mikos
exaly  

Pathophysiological basis of human papillomavirus in penile cancer: Key to prevention and delivery of more effective therapies

Ca-A Cancer Journal for Clinicians, 2016
Adam S Baumgarten, Anna R Giuliano
exaly  

Tissue factor pathway inhibitor.

Methods in enzymology, 1993
T J, Girard, G J, Broze
openaire   +1 more source

Recent developments in the medical and surgical treatment of melanoma

Ca-A Cancer Journal for Clinicians, 2014
Jonathan S Zager
exaly  

Risk of ovarian function recovery should be considered when switching from treatment with adjuvant tamoxifen to aromatase inhibitor therapy in women with chemotherapy-induced amenorrhea

Ca-A Cancer Journal for Clinicians, 2018
Clement Chung
exaly  

Tissue Factor Pathway Inhibitor: Clinical Deficiency States

Thrombosis and Haemostasis, 1997
P M, Sandset, B, Bendz
openaire   +2 more sources